Skip to main content
Top
Published in: Cancer Causes & Control 12/2010

01-12-2010 | Original paper

Models for local implementation of comprehensive cancer control: meeting local cancer control needs through community collaboration

Authors: Bruce Behringer, Staci Lofton, Margaret L. Knight

Published in: Cancer Causes & Control | Issue 12/2010

Login to get access

Abstract

The comprehensive cancer control approach is used by state, tribes, tribal organizations, territorial and Pacific Island Jurisdiction cancer coalitions to spur local implementation of cancer plans to reduce the burden of cancer in jurisdictions across the country. There is a rich diversity of models and approaches to the development of relationships and scope of planning for cancer control activities between coalitions and advocates in local communities. The national comprehensive cancer control philosophy provides an operational framework while support from the Centers for Disease Control and Prevention enables coalitions to act as catalysts to bring local partners together to combat cancer in communities. This manuscript describes multiple characteristics of cancer coalitions and how they are organized. Two models of how coalitions and local partners collaborate are described. A case study method was used to identify how five different state and tribal coalitions use the two models to organize their collaborations with local communities that result in local implementation of cancer plan priorities. Conclusions support the use of multiple organizing models to ensure involvement of diverse interests and sensitivity to local cancer issues that encourages implementation of cancer control activities.
Literature
1.
go back to reference Edwards BK, Ward E, Kohler BA et al (2009) Annual report to the nation on the status of cancer, 1975–2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 116:544–573CrossRef Edwards BK, Ward E, Kohler BA et al (2009) Annual report to the nation on the status of cancer, 1975–2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 116:544–573CrossRef
3.
go back to reference Brinkley WR, Wood J, Garrison HH (1988) Increased funding for NIH: a biomedical science perspective. FASEB J 12:1431–1435 Brinkley WR, Wood J, Garrison HH (1988) Increased funding for NIH: a biomedical science perspective. FASEB J 12:1431–1435
5.
go back to reference Deaths, percent of total deaths, and death rates for the 15 leading causes of death: United States and each state, 2005. Atlanta (GA): Centers for disease control and prevention; 2008. http://www.cdc.gov/nchs/data/ dvs/LCWK9_2005.pdf. Accessed 17 April 2010 Deaths, percent of total deaths, and death rates for the 15 leading causes of death: United States and each state, 2005. Atlanta (GA): Centers for disease control and prevention; 2008. http://​www.​cdc.​gov/​nchs/​data/​ dvs/LCWK9_2005.pdf. Accessed 17 April 2010
6.
go back to reference Lisovicz N, Wynn T, Fouad M, Partride E (2008) Cancer health disparities: what we have done. Am J Med Sci 335(4):254–259CrossRefPubMed Lisovicz N, Wynn T, Fouad M, Partride E (2008) Cancer health disparities: what we have done. Am J Med Sci 335(4):254–259CrossRefPubMed
7.
go back to reference Frieden TR, Myers JE, Krauskopf MS, Farley TA (2008) A public health approach to winning the war on cancer. Oncologist 13:1306–1313CrossRefPubMed Frieden TR, Myers JE, Krauskopf MS, Farley TA (2008) A public health approach to winning the war on cancer. Oncologist 13:1306–1313CrossRefPubMed
8.
go back to reference Given LS, Black B, Lowry G et al (2005) Collaborating to conquer cancer a comprehensive approach to cancer control. Cancer Causes Control 16(Suppl.1):3–14CrossRefPubMed Given LS, Black B, Lowry G et al (2005) Collaborating to conquer cancer a comprehensive approach to cancer control. Cancer Causes Control 16(Suppl.1):3–14CrossRefPubMed
11.
go back to reference Koh HK, Walker DK (2003) The role of state health agencies in cancer prevention and control: lessons learned from Massachusetts. Cancer Epidemiol Biomarkers Prev 12(3):261s–268sPubMed Koh HK, Walker DK (2003) The role of state health agencies in cancer prevention and control: lessons learned from Massachusetts. Cancer Epidemiol Biomarkers Prev 12(3):261s–268sPubMed
12.
go back to reference Georgeson M, Thorpe LE, Medino M et al (2005) Shortchanged? An assessment of chronic disease programming in major US city health departments. J Urban Health 82:183–190PubMed Georgeson M, Thorpe LE, Medino M et al (2005) Shortchanged? An assessment of chronic disease programming in major US city health departments. J Urban Health 82:183–190PubMed
13.
go back to reference Frieden TR (2004) Asleep at the switch: local public health and chronic disease. Am J Public Health 94:2059–2061CrossRefPubMed Frieden TR (2004) Asleep at the switch: local public health and chronic disease. Am J Public Health 94:2059–2061CrossRefPubMed
14.
go back to reference Himmelman AT (2001) On coalitions and the transformation of power relations: collaborative betterment and collaborative empowerment. Am J Community Psychol 29(1):277–284CrossRefPubMed Himmelman AT (2001) On coalitions and the transformation of power relations: collaborative betterment and collaborative empowerment. Am J Community Psychol 29(1):277–284CrossRefPubMed
Metadata
Title
Models for local implementation of comprehensive cancer control: meeting local cancer control needs through community collaboration
Authors
Bruce Behringer
Staci Lofton
Margaret L. Knight
Publication date
01-12-2010
Publisher
Springer Netherlands
Published in
Cancer Causes & Control / Issue 12/2010
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-010-9655-x

Other articles of this Issue 12/2010

Cancer Causes & Control 12/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine